» Authors » Po-Hsun Huang

Po-Hsun Huang

Explore the profile of Po-Hsun Huang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 360
Citations 5761
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tu K, Chang W, Lin H, Lin P, Wu Y, Lin C, et al.
Eur J Med Res . 2025 Mar; 30(1):176. PMID: 40089775
Objective: Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors are a standard therapy for patients who respond poorly to or cannot tolerate statins. However, identifying responders to PCSK9 inhibitors remains unclear....
2.
Shiver A, Sun J, Culver R, Violette A, Wynter C, Nieckarz M, et al.
Cell . 2025 Mar; PMID: 40068681
Bifidobacteria represent a dominant constituent of human gut microbiomes during infancy, influencing nutrition, immune development, and resistance to infection. Despite interest in bifidobacteria as a live biotic therapy, our understanding...
3.
Su Y, Huang P, Hsiao T
J Funct Morphol Kinesiol . 2025 Feb; 10(1). PMID: 39982305
A commonly observed phenomenon is that although the players in a baseball team have received the same training content and volume, their batting performance is quite different. As no optimal...
4.
Chen C, Chang T, Chen C, Hsu S, Chu Y, Huang N, et al.
Sci Rep . 2025 Jan; 15(1):3856. PMID: 39890827
In hospitalized patients, acute kidney injury (AKI) is an important adverse event associated with high mortality and medical costs. Accurate diagnosis and timely management of AKI are essential for improving...
5.
Tsai H, Wang J, Hsu Y, Lin C, Huang P, Tsai M, et al.
Biomed J . 2024 Nov; :100818. PMID: 39586376
Background: Cardiac remodeling is implicated in numerous physiologic and pathologic conditions, including scar formation, heart failure, and cardiac arrhythmias. Nuclear factor-activated T-cell cytoplasmic (NFATc) is a crucial transcription factor that...
6.
Chao T, Lin T, Cheng C, Wu Y, Ueng K, Wu Y, et al.
Acta Cardiol Sin . 2024 Nov; 40(6):669-715. PMID: 39582845
For the primary prevention of atherosclerotic cardiovascular disease (ASCVD), the recommended treatment target for each modifiable risk factor is as follows: reducing body weight by 5-10%; blood pressure < 130/80...
7.
Lee J, Hsieh I, Huang P, Wu Y, Hsu J, Kuo J, et al.
J Formos Med Assoc . 2024 Oct; PMID: 39370366
Background: The effectiveness of Ranolazine on chronic angina had been proved and launched in the United States. This study aimed to determine whether add-on Ranolazine could also be effective in...
8.
Chao T, Lin T, Cheng C, Wu Y, Ueng K, Wu Y, et al.
Acta Cardiol Sin . 2024 Sep; 40(5):479-543. PMID: 39308649
Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of death worldwide and in Taiwan. It is highly prevalent and has a tremendous impact on global health. Therefore, the...
9.
Chen C, Guo J, Chou R, Wu C, Kuo C, Wei J, et al.
Sci Rep . 2024 Aug; 14(1):19848. PMID: 39191876
Elevated serum corin concentrations in patients with cardiac diseases have been associated with adverse cardiovascular events and progressive renal dysfunction. This study aimed to determine the role of serum corin...
10.
Chang C, Sung W, Lu Y, Chuang M, Lee Y, Tsai Y, et al.
Clin Cardiol . 2024 Jul; 47(7):e24317. PMID: 38953595
Introduction: The DESyne novolimus-eluting coronary stent (NES) is a new-generation drug-eluting stent (DES) that is widely used, but clinical data are rarely reported for this stent. We compared the safety...